![Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,t…](https://static.cymitquimica.com/products/3D/img/JMB71436.png "Click to enlarge")
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
CAS: 934714-36-0
Ref. 3D-JMB71436
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
Description:
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate is a prodrug of strontium that is hydrolyzed by esomeprazole and omeprazole to release the active form. Strontium has been shown to be effective in treatment of bowel disease. Strontium inhibits the production of prostaglandins and leukotrienes, leading to decreased inflammation in the gastrointestinal tract. It also has a therapeutic effect on reflux disease. Strontium can cause drug interactions with other drugs metabolized by cytochrome P450 enzymes (e.g., esomeprazole) or that inhibit gastric acid secretion (e.g., omeprazole).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
848.5 g/mol
Formula:
C34H44N6O10S2Sr
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
